Literature DB >> 26091792

Screening strategy to generate cell specific recombination: a case report with the RIP-Cre mice.

Valeria Spinelli1,2,3,4, Céline Martin1,2,3,4, Emilie Dorchies1,2,3,4, Emmanuelle Vallez1,2,3,4, Hélène Dehondt1,2,3,4, Mohamed-Sami Trabelsi1,2,3,4, Anne Tailleux1,2,3,4, Sandrine Caron1,2,3,4, Bart Staels5,6,7,8.   

Abstract

Conditional gene knockout technology is a powerful tool to study the function of a gene in a specific tissue, organ or cell lineage. The most commonly used procedure applies the Cre-LoxP strategy, where the choice of the Cre driver promoter is critical to determine the efficiency and specificity of the system. However, a considered choice of an appropriate promoter does not always protect against the risk of unwanted recombination and the consequent deletion of the gene in other tissues than the desired one(s), due to phenomena of non-specific activation of the Cre transgene. Furthermore, the causes of these phenomena are not completely understood and this can potentially affect every strain of Cre-mice. In our study on the deletion of a same gene in two different tissues, we show that the incidence rate of non-specific recombination in unwanted tissues depends on the Cre driver strain, ranging from 100%, rendering it useless (aP2-Cre strain), to ~5%, which is still compatible with their use (RIP-Cre strain). The use of a simple PCR strategy conceived to detect this occurrence is indispensable when producing a tissue-specific knockout mouse. Therefore, when choosing the Cre-driver promoter, researchers not only have to be careful about its tissue-specificity and timing of activation, but should also include a systematical screening in order to exclude mice in which atypical recombination has occurred and to limit the unnecessary use of laboratory animals in uninterpretable experiments.

Entities:  

Keywords:  Genotyping; Germline recombination; Tissue-specific knockout

Mesh:

Substances:

Year:  2015        PMID: 26091792     DOI: 10.1007/s11248-015-9889-1

Source DB:  PubMed          Journal:  Transgenic Res        ISSN: 0962-8819            Impact factor:   2.788


  30 in total

1.  Transgenesis in creatures great and small Transgenic Animal Technology. A Laboratory Handbook Edited by Carl A. Pinkert San Diego: Academic Press, Inc. (1994). 364 pp.

Authors:  F A Simmen
Journal:  Theriogenology       Date:  1994-08-01       Impact factor: 2.740

2.  Cortical glutamatergic neurons mediate the motor sedative action of diazepam.

Authors:  A Zeller; F Crestani; I Camenisch; T Iwasato; S Itohara; J M Fritschy; U Rudolph
Journal:  Mol Pharmacol       Date:  2007-10-26       Impact factor: 4.436

3.  Synapsin I Cre transgene expression in male mice produces germline recombination in progeny.

Authors:  D Rempe; G Vangeison; J Hamilton; Y Li; M Jepson; H J Federoff
Journal:  Genesis       Date:  2006-01       Impact factor: 2.487

4.  Generating conditional knockout mice.

Authors:  Roland H Friedel; Wolfgang Wurst; Benedikt Wefers; Ralf Kühn
Journal:  Methods Mol Biol       Date:  2011

5.  Brain expression of Cre recombinase driven by pancreas-specific promoters.

Authors:  Junghun Song; Yuanzhong Xu; Xiaoxia Hu; Brian Choi; Qingchun Tong
Journal:  Genesis       Date:  2010-10-19       Impact factor: 2.487

6.  Genetic background alters the spectrum of tumors that develop in p53-deficient mice.

Authors:  M Harvey; M J McArthur; C A Montgomery; A Bradley; L A Donehower
Journal:  FASEB J       Date:  1993-07       Impact factor: 5.191

7.  Cre transgenic mouse lines.

Authors:  Xin Wang
Journal:  Methods Mol Biol       Date:  2009

8.  A novel adipose-specific gene deletion model demonstrates potential pitfalls of existing methods.

Authors:  Shannon E Mullican; Takuya Tomaru; Christine A Gaddis; Lindsey C Peed; Anand Sundaram; Mitchell A Lazar
Journal:  Mol Endocrinol       Date:  2012-11-28

9.  Lessons on conditional gene targeting in mouse adipose tissue.

Authors:  Kevin Y Lee; Steven J Russell; Siegfried Ussar; Jeremie Boucher; Cecile Vernochet; Marcelo A Mori; Graham Smyth; Michael Rourk; Carly Cederquist; Evan D Rosen; Barbara B Kahn; C Ronald Kahn
Journal:  Diabetes       Date:  2013-01-15       Impact factor: 9.461

10.  Germ-line recombination activity of the widely used hGFAP-Cre and nestin-Cre transgenes.

Authors:  Jiong Zhang; Pavel Dublin; Stephanie Griemsmann; Alexandra Klein; Ralph Brehm; Peter Bedner; Bernd K Fleischmann; Christian Steinhäuser; Martin Theis
Journal:  PLoS One       Date:  2013-12-09       Impact factor: 3.240

View more
  2 in total

Review 1.  Detecting and Avoiding Problems When Using the Cre-lox System.

Authors:  Allisa J Song; Richard D Palmiter
Journal:  Trends Genet       Date:  2018-01-11       Impact factor: 11.639

2.  Prostaglandin EP3 receptor signaling is required to prevent insulin hypersecretion and metabolic dysfunction in a non-obese mouse model of insulin resistance.

Authors:  Jaclyn A Wisinski; Austin Reuter; Darby C Peter; Michael D Schaid; Rachel J Fenske; Michelle E Kimple
Journal:  Am J Physiol Endocrinol Metab       Date:  2021-07-06       Impact factor: 4.310

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.